Lymphohaematopoietic Growth Factors in Cancer Therapy

1. Front Matter

   Pages I-VII

   PDF

2. Introduction

   • Roland Mertelsmann

   Pages 1-1

3. Interleukins and Haematopoietic Growth Factors

   • F. M. Rosenthal, A. Lindemann, F. Herrmann, R. Mertelsmann

   Pages 3-17

4. Mechanisms of T-Cell Activation

   • Hermann Wagner, Klaus Heeg

   Pages 19-23

5. Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals

   • Ronald B. Herberman

   Pages 25-35

6. Interleukin 2: In Vivo Induction of Effector Cells

   • Guido Forni, Maria Carla Bosco, Stefania Vai, Mirella Giovarelli

   Pages 37-46

7. Cellular Immunotherapy of Cancer: The use of Lymphokine-Activated Natural Killer (LANAK) Cells

   • Françoise Farace, Bernard Escudier, Frédéric Triebel, Thierry Hercend

   Pages 47-56

8. Interleukin 2: Clinical Aspects

   • N. Thatcher

   Pages 57-77

9. Interleukin 2 and LAK Cells

   • Federico Calabresi, Enzo Maria Ruggeri

   Pages 79-90

10. Back Matter

    Pages 91-91

    PDF

Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the ESO Monographs series. The discussion revolves on the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research.

• cancer research
• cancer therapy
• cytokine
• cytokines
• hematology
• immunology
• immunotherapy
• oncology

• Abteilung Innere Medizin I, Klinikum der Albert-Ludwigs-Universität Hugstetter, Freiburg, Federal Republic of Germany

  Roland Mertelsmann

Policies and ethics